高级检索
当前位置: 首页 > 详情页

miR-19 targeting of GSK3 beta mediates sulforaphane suppression of lung cancer stem cells

文献详情

资源类型:
机构: [1]Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Safety, 818 East Tianyuan Rd, Nanjing 211166, Jiangsu, Peoples R China; [2]Sun Yat Sen Univ, Dept Clin Nutr, Canc Ctr, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou 510060, Guangdong, Peoples R China; [3]Sun Yat Sen Univ, Dept Clin Nutr, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
出处:
ISSN:

关键词: Lung cancer stem cells Wnt/beta-catenin pathway miR-19 GSK3 beta Sulforaphane

摘要:
Cancer stem cells (CSCs) play a central role in the development of cancer. The canonical Wnt/beta-catenin pathway is critical for maintaining sternness of CSCs. Phytochemicals from dietary compounds possess anti-CSCs properties and have been characterized as promising therapeutic agents for the prevention and treatment of many cancers. To date, the involvement and function of miR-19, a key oncogenic miRNA, in regulating Wnt/beta-catenin pathway and lung CSCs has not been defined. Meanwhile, the effect of sulforaphane (SFN) on lung CSCs also remains to be elucidated. Here, we reported that lung CSCs up-regulated miR19a and miR-19b expression. Overexpression of miR-19a/19b enhanced the ability of tumorsphere formation, uti-regulated the expression of lung CSCs markers, increased Wnt/beta-catenin pathway activation and (beta-catenin/TCF transcriptional activity in lung CSCs. In contrary, down-regulation of miR-19 suppressed lung CSCs activity and Wnt/beta-catenin activation. We further revealed that miR-19 activated Wnt/beta-catenin pathway by directly targeting GSK3 beta, the key negative modulator of this pathway. Moreover, we showed that SFN exhibited inhibitory effect on lung CSCs through suppressing miR-19 and Wnt/beta-catenin pathway. Taken together, these data illustrate the role of miR-19 in regulating lung CSCs traits and miR-19/GSK3 beta/beta-catenin axis in SFN intervention of lung CSCs. Findings from this study could provide important new insights into the molecular mechanisms of lung CSCs regulation as well as its target intervention. (C) 2017 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 生化与分子生物学 2 区 营养学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 生化与分子生物学 2 区 营养学
第一作者:
第一作者机构: [1]Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Safety, 818 East Tianyuan Rd, Nanjing 211166, Jiangsu, Peoples R China;
通讯作者:
通讯机构: [1]Nanjing Med Univ, Sch Publ Hlth, Dept Nutr & Food Safety, 818 East Tianyuan Rd, Nanjing 211166, Jiangsu, Peoples R China; [2]Sun Yat Sen Univ, Dept Clin Nutr, Canc Ctr, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou 510060, Guangdong, Peoples R China; [3]Sun Yat Sen Univ, Dept Clin Nutr, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号